Home / Inspections / 850690

FDA Inspection 850690 — BioReliance Corporation

BioReliance Corporation — FEI 1122041

The FDA completed an inspection of BioReliance Corporation on August 29, 2013 in Rockville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 29, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Rockville, MD (United States)

Facility

Other inspections at this facility

  • 1295306 (VAI Thu Jan 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1254934 (VAI Fri Nov 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215040 (NAI Fri Aug 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1059115 (VAI Fri Jul 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983525 (NAI Mon Jan 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources